Research programme: neurological disorder therapeutics - Organon

Drug Profile

Research programme: neurological disorder therapeutics - Organon

Alternative Names: AMPA receptor inhibitors - Organon; Ampakine compounds - Organon

Latest Information Update: 13 Oct 2010

Price : $50

At a glance

  • Originator Organon
  • Class Small molecules
  • Mechanism of Action AMPA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Major depressive disorder; Schizophrenia

Most Recent Events

  • 02 Feb 2001 Preclinical development for Depression in USA (PO)
  • 02 Feb 1999 Preclinical trials in Schizophrenia in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top